UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 39,353	$ 45,359
Adjustments to reconcile net income to cash provided by operating activities:
Deferred income tax provision, net	(2,852)	(757)
Provision for credit losses	136	325
Depreciation and amortization	4,431	3,776
Stock-based compensation expense	10,548	14,602
Noncash lease expense	2,765	3,111
Loss on equity method investment	0	750
Other	(685)	675
(Increase) decrease in operating assets
Trade receivables, net	4,032	20,880
Other assets	(4,072)	(289)
Increase (decrease) in operating liabilities
Accrued payroll costs	13,085	(4,812)
Other liabilities	(1,657)	(14,564)
Cash provided by operating activities	65,084	69,056
Cash flows from investing activities:
Capital expenditures	(8,501)	(6,076)
Proceeds from Life Insurance Policy	2,377	0
Payment to Acquire Life Insurance Policy, Investing Activities	1,777	765
Proceeds from the sale of our joint venture interest	0	5,059
Note receivable issued to our joint venture	0	(750)
Cash used in investing activities	(7,901)	(2,532)
Cash flows from financing activities:
Proceeds from credit facility	173,600	426,400
Payments on credit facility	(188,300)	(430,600)
Repurchases of common stock	(21,189)	(41,470)
Cash dividends	(21,282)	(20,842)
Other	(4)	(11)
Cash used in financing activities	(57,175)	(66,523)
Change in cash and cash equivalents	8	1
Cash and cash equivalents, beginning of period	119	121
Cash and cash equivalents, end of period	127	122
Supplemental Disclosure of Cash Flow Information
Income taxes, net	9,085	19,323
Operating lease liabilities	3,609	3,937
Interest, net	1,556	623
Non-Cash Investing and Financing Transactions:
ROU assets obtained from operating leases	2,627	3,692
Employee stock purchase plan	612	817
Unsettled repurchases of common stock	$ 500	$ 2,292